Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for Thrombocytopenia in HCV-Related Liver Cirrhosis
NCT07791940Phase 4Completed
- Sponsor
- Fayoum University Hospital
- Start
- Oct 2015
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
A Phase 4 trial of rifaximin in Thrombocytopenia, sponsored by Fayoum University Hospital. Started Oct 2015; status: completed.
02
Drugs
rifaximin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT07791940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07791940.